- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Hospital CEO Pay Not Tied to Quality of Care: Study
Hospital CEOs' pay isn't linked to their hospital's benefit to the community. Nor is it linked to the quality of care the hospital provides, a new study found.
Hospital CEOs' pay isn't linked to their hospital's benefit to the community. Nor is it linked to the quality of care the hospital provides, a new study found.
Instead, the chief executive officers, or CEOs, tended to earn more at hospitals with high patient satisfaction ratings and advanced technology.
"I was hoping I'd see even some modest relationship with quality performance," said Dr. Ashish Jha. "I think we were a little disappointed."
Jha worked on the study at the Harvard School of Public Health in Boston. He and his colleagues combined data from tax returns, hospital surveys and performance and cost reports.
They looked at CEO paychecks in 2009 alongside hospital size, quality and other data from 2008, figuring salaries and bonuses might be tied to the prior year's figures.
The study included 1,877 CEOs from 2,681 private, non-profit hospitals across the country. The average executive earned about $596,000. (In comparison, according to the Economic Policy Institute, CEOs at the top 350 U.S. companies made an average of $14.1 million each in 2012.)
Read the full story here: http://reut.rs/17DLxKq
Source: Reuters
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
